Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a New Family of HIV Latency Regulators (LRAs) Targeting the Tat Viral Protein

NCT06441123 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT06441123
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06441123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a New Family of HIV Latency Regulators (LRAs) Targeting the Tat Viral Protein
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Recruiting
Start date
February 10, 2025
Completion date
February 10, 2027
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections